Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2025-03-14
• Last 15 days FTD volume: C$1.12 M
• Last 3 months FTD volume: C$10.58 M
• Last year FTD volume: C$10.58 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Amgen AMGN	C$97.9 M	C$0.29 B	🇺🇸 USA
Vertex Pharmaceuticals VRTX	C$17.87 M	C$55.65 M	🇺🇸 USA
AbbVie ABBV	C$34.68 M	C$0.20 B	🇺🇸 USA
Illumina ILMN	C$16.56 M	C$70.3 M	🇺🇸 USA
Biogen BIIB	C$25.8 M	C$75.55 M	🇺🇸 USA
Pfizer PFE	C$32.79 M	C$0.34 B	🇺🇸 USA
Johnson & Johnson JNJ	C$16.63 M	C$0.20 B	🇺🇸 USA
Eli Lilly LLY	C$70.56 M	C$0.20 B	🇺🇸 USA
Merck MRK	C$0.10 B	C$0.17 B	🇺🇸 USA